Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis.
暂无分享,去创建一个
K. Geisinger | E. Levine | B. Loggie | P. Shen | R. Fleming | R. McQuellon | G. Russell | D. Case | Jason J. Hall
[1] K. Geisinger,et al. Prospective Trial for the Treatment of Malignant Peritoneal Mesothelioma , 2001, The American surgeon.
[2] M. Ducreux,et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy , 2001, Cancer.
[3] F. van Coevorden,et al. Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin. , 2001, European journal of cancer.
[4] M. Manns,et al. Improved prognosis following peritonectomy procedures and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from appendiceal carcinoma. , 2001, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[5] F. van Coevorden,et al. Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei , 2001, The British journal of surgery.
[6] S. Mocellin,et al. Multimodal treatment of peritoneal carcinomatosis and sarcomatosis. , 2001, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[7] B. Loggie,et al. Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis. , 2001, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[8] P. Sugarbaker,et al. Treatment of primary colon cancer with peritoneal carcinomatosis , 2000, Diseases of the colon and rectum.
[9] D. Giannarelli,et al. Peritonectomy and hyperthermic antiblastic perfusion in the treatment of peritoneal carcinomatosis. , 2000, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[10] F. Gilly,et al. Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis , 2000, Cancer.
[11] K. Geisinger,et al. Cytoreductive Surgery with Intraperitoneal Hyperthermic Chemotherapy for Disseminated Peritoneal Cancer of Gastrointestinal Origin , 2000, The American surgeon.
[12] J. Faure,et al. Peritoneal carcinomatosis from non‐gynecologic malignancies , 2000, Cancer.
[13] P. Sugarbaker,et al. Results of Treatment of 385 Patients With Peritoneal Surface Spread of Appendiceal Malignancy , 1999, Annals of Surgical Oncology.
[14] J. Esquivel,et al. Morbidity and Mortality Analysis of 200 Treatments With Cytoreductive Surgery and Hyperthermic Intraoperative Intraperitoneal Chemotherapy Using the Coliseum Technique , 1999, Annals of Surgical Oncology.
[15] S. Libutti,et al. Treatment of Primary Peritoneal Mesothelioma by Continuous Hyperthermic Peritoneal Perfusion (CHPP) , 1999, Annals of Surgical Oncology.
[16] P. Schwartz,et al. Neoadjuvant chemotherapy for advanced ovarian cancer: long-term survival. , 1999, Gynecologic oncology.
[17] S. Libutti,et al. A Phase I trial of continuous hyperthermic peritoneal perfusion with tumor necrosis factor and cisplatin in the treatment of peritoneal carcinomatosis , 1998, Cancer.
[18] K. Jablonski,et al. Prognostic Features of 51 Colorectal and 130 Appendiceal Cancer Patients with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy , 1995, Annals of surgery.
[19] P. Sugarbaker. Pseudomyxoma peritonei. A cancer whose biology is characterized by a redistribution phenomenon. , 1994, Annals of surgery.
[20] P. Sugarbaker,et al. Morbidity and mortality of cytoreductive surgery and intraperitoneal chemotherapy. , 1993, Surgery.
[21] B. Shmookler,et al. Peritoneal carcinomatosis from appendiceal cancer: Results in 69 patients treated by cytoreductive surgery and intraperitoneal chemotherapy , 1993, Diseases of the colon and rectum.
[22] T. Kosaka,et al. Hyperthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination , 1991, World Journal of Surgery.
[23] K. Westbrook,et al. Peritioneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors , 1989, Cancer.
[24] Dedrick Rl. Theoretical and experimental bases of intraperitoneal chemotherapy. , 1985 .
[25] C. Wong,et al. Total abdominal irradiation for cancer of the colon. , 1984, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[26] P. Ganz,et al. Karnofsky performance status revisited: reliability, validity, and guidelines. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] R K Jain,et al. Differential response of normal and tumor microcirculation to hyperthermia. , 1984, Cancer research.
[28] G. Steel,et al. Response of two mouse tumours to hyperthermia with CCNU or melphalan. , 1982, British Journal of Cancer.
[29] B. Teicher,et al. Enhancement by hyperthermia of the in vitro cytotoxicity of mitomycin C toward hypoxic tumor cells. , 1981, Cancer research.
[30] J. Spratt,et al. Clinical delivery system for intraperitoneal hyperthermic chemotherapy. , 1980, Cancer research.
[31] N Gunduz,et al. Effect of surgical removal on the growth and kinetics of residual tumor. , 1979, Cancer research.
[32] L Simpson-Herren,et al. Effects of surgery on the cell kinetics of residual tumor. , 1976, Cancer treatment reports.
[33] B. Giovanella,et al. Selective lethal effect of supranormal temperatures on human neoplastic cells. , 1976, Cancer research.
[34] J. Mcvie,et al. Pentetration of carboplatin and cisplatin into rat peritoneal tumor nodules after intraperitoneal chemotherapy , 2004, Cancer Chemotherapy and Pharmacology.
[35] M. McCarter,et al. Role for Surgical Cytoreduction in Multimodality Treatments for Cancer , 2001, Annals of Surgical Oncology.
[36] R. Tanaka,et al. Effects of antineoplastic agents and hyperthermia on cytotoxicity toward chronically hypoxic glioma cells. , 1992, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[37] M. Markman. Intraperitoneal therapy in ovarian cancer utilizing agents achieving high local but low systemic exposures , 1991 .
[38] R. Dedrick,et al. Theoretical and experimental bases of intraperitoneal chemotherapy. , 1985, Seminars in oncology.